Analyst Summary
- DarioHealth Corp. replaced its independent registered public accounting firm, dismissing Ernst & Young (EY) and engaging Kesselman & Kesselman (PwC) on March 12, 2025.
- EY’s audit reports for the fiscal years ended December 31, 2024 and 2023 had no adverse opinions, disclaimers, qualifications, or modifications regarding uncertainty, audit scope, or accounting principles.
- There were no disagreements between DarioHealth and EY on accounting principles, practices, financial statement disclosure, or auditing scope/procedure during the fiscal years ended December 31, 2024 and 2023, and the subsequent interim period through March 12, 2025.
- DarioHealth consulted with PwC on accounting matters relating to financial reporting, valuation of financial instruments, incremental borrowing rates, and goodwill impairment tests during the fiscal years ended December 31, 2024 and 2023.